Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 18978116)

1.

Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort study.

Chughtai B, Mao J, Buck J, Kaplan S, Sedrakyan A.

BMJ. 2015 Jun 2;350:h2685. doi: 10.1136/bmj.h2685.

2.

Short-term outcomes of vaginal mesh placement among female Medicare beneficiaries.

Anger JT, Khan AA, Eilber KS, Chong E, Histed S, Wu N, Pashos CL, Clemens JQ.

Urology. 2014 Apr;83(4):768-73. doi: 10.1016/j.urology.2013.10.072.

3.

Clinical challenges in the management of vaginal prolapse.

Siddiqui NY, Edenfield AL.

Int J Womens Health. 2014 Jan 16;6:83-94. doi: 10.2147/IJWH.S54845. eCollection 2014. Review.

4.

The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk.

Ellington DR, Richter HE.

Obstet Gynecol Int. 2013;2013:356960. doi: 10.1155/2013/356960. Epub 2013 Aug 28. Review.

5.

Indications, contraindications, and complications of mesh in surgical treatment of pelvic organ prolapse.

Ellington DR, Richter HE.

Clin Obstet Gynecol. 2013 Jun;56(2):276-88. doi: 10.1097/GRF.0b013e318282f2e8. Review.

6.

Long-term outcomes of vaginal mesh versus native tissue repair for anterior vaginal wall prolapse.

Jonsson Funk M, Visco AG, Weidner AC, Pate V, Wu JM.

Int Urogynecol J. 2013 Aug;24(8):1279-85. doi: 10.1007/s00192-013-2043-9. Epub 2013 Feb 12.

7.

Surgical treatment of persistent vaginal granulation tissue using CO(2) laser vaporization under colposcopic and laparoscopic guidance.

Steinberg BJ, Mapp T, Mama S, Echols KT.

JSLS. 2012 Jul-Sep;16(3):488-91. doi: 10.4293/108680812X13462882736619.

8.

Is mesh becoming more popular? Dilemmas in urogynecology: a national survey.

Condrea A, Netzer I, Ginath S, Eldor-Itskovitz J, Golan A, Lowenstein L.

Obstet Gynecol Int. 2012;2012:672356. doi: 10.1155/2012/672356. Epub 2011 Nov 15.

9.

Porcine subintestinal submucosal graft augmentation for rectocele repair: a randomized controlled trial.

Sung VW, Rardin CR, Raker CA, Lasala CA, Myers DL.

Obstet Gynecol. 2012 Jan;119(1):125-33. doi: 10.1097/AOG.0b013e31823d407e.

10.

A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding.

Matteson KA, Abed H, Wheeler TL 2nd, Sung VW, Rahn DD, Schaffer JI, Balk EM; Society of Gynecologic Surgeons Systematic Review Group.

J Minim Invasive Gynecol. 2012 Jan-Feb;19(1):13-28. doi: 10.1016/j.jmig.2011.08.005. Epub 2011 Nov 11. Review.

11.

Single-incision vaginal approach to treat cystocele and vault prolapse with an anterior wall mesh anchored apically to the sacrospinous ligaments.

Moore RD, Mitchell GK, Miklos JR.

Int Urogynecol J. 2012 Jan;23(1):85-91. doi: 10.1007/s00192-011-1536-7. Epub 2011 Aug 25.

12.

A multicenter prospective trial evaluating fetal bovine dermal graft (Xenform® Matrix) for pelvic reconstructive surgery.

Goldstein HB, Maccarone J, Naughton MJ, Aguirre OA, Patel RC.

BMC Urol. 2010 Dec 13;10:21. doi: 10.1186/1471-2490-10-21.

13.

Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials.

Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, Barber MD, Schaffer JI, Wheeler TL 2nd, Balk EM, Uhlig K; Society of Gynecologic Surgeons-Systematic Review Group.

J Clin Epidemiol. 2011 Mar;64(3):293-300. doi: 10.1016/j.jclinepi.2010.03.017. Epub 2010 Aug 12. Review.

14.

Vaginal tactile imaging.

Egorov V, van Raalte H, Sarvazyan AP.

IEEE Trans Biomed Eng. 2010 Jul;57(7):1736-44. doi: 10.1109/TBME.2010.2045757. Epub 2010 May 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk